Followers | 12 |
Posts | 1060 |
Boards Moderated | 0 |
Alias Born | 06/29/2017 |
Wednesday, April 21, 2021 11:22:46 PM
About Heat Biologics
Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, and a COVID-19 vaccine program in preclinical development. In addition, Heat is also developing a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.
Job Description
This position is an integral member of the business development (BD) team. We are seeking a highly motivated individual with a background in biology/ immunology. The ideal candidate may be a recent graduate in a PhD program in biology / immunology who has an interest in a business career versus a research career. Prior work experience in tech transfer, biopharmaceutical industry or consulting is preferred. This individual will contribute to Heat Biologics’ corporate BD goals and objectives, support the BD and commercial strategy and alliance management functions. This position reports to the Chief of Staff and Director of Business Development and will interact directly with the company’s management team.
This position is office-based in Heat Biologics’ headquarter office in Research Triangle Park Area of North Carolina. During COVID-19, the option of working remotely is available and transition to fully office-based arrangement will be determined per company health and safety guidelines.
Responsibilities
Support all aspects of corporate development and business development activities
Contribute to corporate strategy, partnership strategy and product development strategy in collaboration with the senior management team
Support and coordinate meetings for Chief of Staff including internal and external communications
Manage BD tracking database
Monitor market intelligence and competitive landscape on therapeutics areas and targets relevant to current and future Heat Biologics pipeline portfolio
Develop and update all external presentations (including corporate, partnership, scientific and clinical presentation materials) in collaboration with the rest of the BD team
Liaise with all departments to support corporate planning and partnering activities
Qualifications
MD or PhD in one of the relevant Biological Sciences
Prior work experience in biopharmaceutical industry or major management consulting firms preferred
High energy individual with positive attitude and strong communication, facilitation and interpersonal skills
Good understanding of drug discovery and development processes preferred
Ability to interface and collaborate with internal and external cross-functional teams
Strategic thinker with good quantitative analytical abilities and ability to understand and translate complex scientific concepts into core business objectives
Working knowledge of business valuations or biostatistics a strong plus
Ability to work independently and collaboratively in a fast-paced entrepreneurial environment
Strong attention to detail
Must be able to multi-task and prioritize to management multiple projects simultaneously
Proficient in PowerPoint, Excel and Word
Travel (up to 20%) may be required
POSTED ON THEIR WEBSITE
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM